Lifelong Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
1,189
+15
+1% +$15.3K 0.34% 34
2026
Q1
$1.08M Buy
1,174
+5
+0.4% +$5.07K 0.29% 35
2025
Q4
$1.26M Buy
1,169
+5
+0.4% +$4.78K 0.33% 36
2025
Q3
$888K Sell
1,164
-5
-0.4% -$3.72K 0.26% 34
2025
Q2
$911K Buy
1,169
+59
+5% +$45.8K 0.3% 32
2025
Q1
$917K Buy
1,110
+10
+0.9% +$8.32K 0.43% 29
2024
Q4
$849K Buy
+1,100
New +$911K 0.38% 28

Other funds holding LLY

Lifelong Wealth Advisors's LLY Position: Q2 2026 in Review

Lifelong Wealth Advisors increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $15.3K and bringing the position to 1,189 shares worth $1.43M. The position accounts for 0.34% of the portfolio, ranked #34.

Lifelong Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lifelong Wealth Advisors held 1,189 shares of Eli Lilly worth $1.43M as of Q2 2026.
  • Lifelong Wealth Advisors bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.34% of Lifelong Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • Lifelong Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lifelong Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.